Terms: = Kidney tumors AND ENO2, HEL-S-279, NSE AND Treatment
19 results:
1. eno2 affects the EMT process of renal cell carcinoma and participates in the regulation of the immune microenvironment.
Chen WJ; Yang W; Gong M; He Y; Xu D; Chen JX; Chen WJ; Li WY; Wang YQ; Dong KQ; Song X; Pan XW; Cui XG
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36562383
[TBL] [Abstract] [Full Text] [Related]
2. Overexpression of enolase 2 is associated with worsened prognosis and increased glycikolysis in papillary renal cell carcinoma.
Sun C; Liu M; Zhang W; Wang S; Qian G; Wang M; Zhang G
J Cell Physiol; 2021 May; 236(5):3821-3831. PubMed ID: 33135164
[TBL] [Abstract] [Full Text] [Related]
3. [Comprehensive treatment of adrenal cortical carcinoma].
Deng JH; Li HZ; Ji ZG; Zhang YS; Liu GH
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Apr; 51(2):298-301. PubMed ID: 30996372
[TBL] [Abstract] [Full Text] [Related]
4. Asynchronous tumour quadruplicity: rectosigmoid adenocarcinoma, renal cell carcinoma, prostate adenocarcinoma and neuroendocrine small-cell lung cancer - a case report.
Adwan R; Prošvic P; Prošvicová J; Tomšová M
Rozhl Chir; 2018; 97(9):427-431. PubMed ID: 30470124
[TBL] [Abstract] [Full Text] [Related]
5. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
[TBL] [Abstract] [Full Text] [Related]
6. [Clinicopathological features and differential diagnosis of metanephric adenoma: a report of sixteen cases].
Xi CG; Fan Y; Yang XY; Liu LB; Wang JH; Hu S; Li YY; He Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):598-602. PubMed ID: 29263496
[TBL] [Abstract] [Full Text] [Related]
7. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
[TBL] [Abstract] [Full Text] [Related]
8. Clinical management of small-cell carcinoma of the urinary tract: a 10-year single-center's experience.
Carranza OE; Castañón E; Abella LE; Zudaire ME; Castillo A; Arévalo E; Fusco JP; Zudaire JJ; Carías R; Cambeiro M; Martínez-Monge R; Gil-Bazo I
Clin Genitourin Cancer; 2013 Jun; 11(2):168-74. PubMed ID: 23146567
[TBL] [Abstract] [Full Text] [Related]
9. Primary neuroendocrine carcinoma of the kidney.
Dvorackova J; Macak J; Brzula P; Tomanova R; Dokulil J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2013 Sep; 157(3):257-60. PubMed ID: 23073523
[TBL] [Abstract] [Full Text] [Related]
10. [Unusual intra-abdominal tumor].
Kallel R; Ayadi L; Masmoudi A; Makni S; Beyrouti I; Frikha M; Boudawara T
Rev Med Brux; 2008; 29(3):180-3. PubMed ID: 18705600
[TBL] [Abstract] [Full Text] [Related]
11. Case report: intra-renal paraganglioma masquerading as a renal cyst.
Rafique M; Bhutta RA; Muzzafar S
Int Urol Nephrol; 2003; 35(4):475-8. PubMed ID: 15198147
[TBL] [Abstract] [Full Text] [Related]
12. Neuroblastoma preoperatively treated as nephroblastoma: does inadequate therapy worsen the prognosis?
Hero B; Graf N; Simon T; Weirich A; Tröger J; Berthold F
Klin Padiatr; 2002; 214(4):157-61. PubMed ID: 12165895
[TBL] [Abstract] [Full Text] [Related]
13. [Primary neuroectodermal tumor (PNET) of the kidney: 26 cases. Current status of its diagnosis and treatment].
Cuesta Alcalá JA; Solchaga Martínez A; Caballero Martínez MC; Gómez Dorronsoro M; Pascual Piédrola I; Ripa Saldías L; Aldave Villanueva J; Arrondo Arrondo JL; Grasa Lanau V; Ponz González M; Ipiens Aznar A
Arch Esp Urol; 2001 Dec; 54(10):1081-93. PubMed ID: 11852516
[TBL] [Abstract] [Full Text] [Related]
14. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
Yaman O; Baltaci S; Arikan N; Ozdiler E; Göğüş O; Müftüoğlu YZ
Int Urol Nephrol; 1996; 28(2):207-10. PubMed ID: 8836790
[TBL] [Abstract] [Full Text] [Related]
15. Establishment of a human cell line secreting neuron-specific enolase from a primitive neuroectodermal tumor of the retroperitoneal cavity.
Nakashima J; Horiguchi Y; Ueno M; Nakamura K; Tachibana M; Hata J; Tazaki H
Jpn J Cancer Res; 1995 Dec; 86(12):1172-8. PubMed ID: 8636006
[TBL] [Abstract] [Full Text] [Related]
16. Primitive neuroectodermal tumor of the retroperitoneal cavity.
Horiguchi Y; Nakashima J; Ishii T; Hata J; Tazaki H
Urology; 1994 Jul; 44(1):127-9. PubMed ID: 8042253
[TBL] [Abstract] [Full Text] [Related]
17. Malignant rhabdoid tumor. A morphological and flow cytometric study.
Schmidt D; Leuschner I; Harms D; Sprenger E; Schäfer HJ
Pathol Res Pract; 1989 Feb; 184(2):202-10. PubMed ID: 2469068
[TBL] [Abstract] [Full Text] [Related]
18. Neuron specific enolase: a marker of (small cell) cancers of neuronal and neuroendocrine origin.
Cooper EH
Biomed Pharmacother; 1985; 39(4):165-6. PubMed ID: 2998499
[TBL] [Abstract] [Full Text] [Related]
19. Determination of three enolase isozymes and S-100 protein in various tumors in children.
Ishiguro Y; Kato K; Ito T; Nagaya M
Cancer Res; 1983 Dec; 43(12 Pt 1):6080-4. PubMed ID: 6315226
[TBL] [Abstract] [Full Text] [Related]
